Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Other Non-Current Liabilities (2022 - 2023)

iBio (IBIO) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $263000.0 as the latest value for Q3 2023.

  • Quarterly Other Non-Current Liabilities changed N/A to $263000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $263000.0 through Sep 2023, changed N/A year-over-year, with the annual reading at $527000.0 for FY2023, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q3 2023 was $263000.0 at iBio, down from $527000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $1.1 million in Q4 2022, with the low at $263000.0 in Q3 2023.